Sandoz Strikes €150m Deal On Antibiotics In Austria
Joint Investment With Austrian Government Strengthens European Manufacturing Against COVID Backdrop
Sandoz has announced joint plans with the Austrian government to invest over €150m in antibiotics manufacturing.
You may also be interested in...
Sandoz’s Saynor Reflects On Industry Challenges
In the third and final part of his exclusive interview with Generics Bulletin, Sandoz CEO Richard Saynor discusses global off-patent industry challenges including antibiotics shortages, PBM behavior in the US and the UK’s VPAS rebate mechanism.
Sandoz To Pump Another €50m Into Kundl Antibiotics Site
To increase manufacturing capacity for finished dosage form penicillins, Sandoz is investing another €50m into its key antibiotics site in Kundl, Austria. But the company feels that fundamental reforms are needed from regulators to ensure the long-term sustainability of European-based antibiotic manufacturing and supply.
Sandoz Invests In Its Unique Antibiotics Offering
In the wake of a major deal to acquire GlaxoSmithKline’s cephalosporins business, Sandoz CEO Richard Saynor has set out why the company’s unique position means that antibiotics are an important area for investments, in an exclusive interview with Generics Bulletin.